Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.

Gilead Sciences and LEO Pharma have entered a strategic collaboration to expedite the development and commercialisation of the latter’s small molecule oral signal transducer and activator of ...

Major moves in the pharmaceutical industry include Ownership Matters recommending support for the Chemist Warehouse-Sigma Healthcare merger, J&J's potential bid for Intra-Cellular Therapies, and ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN – Research Report), Rhythm ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

Rates of myalgic encephalomyelitis/chronic fatigue syndrome have dramatically increased since pre-pandemic times. A new large ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...